Effect of the CYP2C19 polymorphism on the eradication rate of Helicobacter pylori infection by 7-day triple therapy with regular proton pump inhibitor dosage. [electronic resource]
Producer: 20090113Description: 1287-91 p. digitalISSN:- 1440-1746
- 2-Pyridinylmethylsulfinylbenzimidazoles -- administration & dosage
- Adult
- Amoxicillin -- administration & dosage
- Anti-Bacterial Agents -- administration & dosage
- Aryl Hydrocarbon Hydroxylases -- genetics
- Clarithromycin -- administration & dosage
- Cytochrome P-450 CYP2C19
- Drug Therapy, Combination
- Esomeprazole -- administration & dosage
- Female
- Helicobacter Infections -- drug therapy
- Helicobacter pylori
- Humans
- Male
- Middle Aged
- Pantoprazole
- Polymorphism, Genetic
- Proton Pump Inhibitors -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.